News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
540,205 Results
Type
Article (36754)
Company Profile (554)
Press Release (502879)
Multimedia
Podcasts (227)
Webinars (27)
Section
Business (162804)
Career Advice (2845)
Deals (26716)
Drug Delivery (163)
Drug Development (73733)
Employer Resources (172)
FDA (11972)
Job Trends (11209)
News (254603)
Policy (21950)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (2157)
Academic (1)
Accelerated approval (60)
ADA (51)
Adcomms (38)
Allergies (198)
Alliances (34230)
ALS (253)
Alzheimer's disease (1790)
Antibody-drug conjugate (ADC) (643)
Approvals (12500)
Artificial intelligence (869)
ASCO (325)
Autoimmune disease (428)
Automation (60)
Bankruptcy (245)
Belgium (8)
Best Places to Work (9019)
BIO (73)
Biologics (14)
BIOSECURE Act (18)
Biosimilars (240)
BioSpace Insights (200)
Biotechnology (331)
Bispecific (3)
Bladder cancer (223)
Brain cancer (93)
Breast cancer (861)
Cancer (6936)
Cardiovascular disease (595)
Career advice (2413)
Career pathing (59)
CAR-T (421)
CDC (54)
CDMO (166)
Celiac Disease (4)
Cell therapy (1121)
Cervical cancer (53)
Clinical research (66172)
Collaboration (2388)
Commercialization (12)
Company closure (9)
Compensation (1604)
Complete response letters (111)
COVID-19 (2426)
CRISPR (135)
C-suite (1369)
Cystic fibrosis (165)
Data (9398)
Decentralized trials (2)
Denatured (77)
Depression (203)
Dermatology (129)
Diabetes (727)
Diagnostics (4906)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (36)
Drug discovery (468)
Drug pricing (192)
Drug shortages (28)
Duchenne muscular dystrophy (354)
Earnings (68766)
Editorial (82)
Employer branding (24)
Employer resources (151)
Events (90984)
Executive appointments (1157)
Eye disease (1)
FDA (16318)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (38)
Funding (2029)
Gene editing (287)
Generative AI (89)
Gene therapy (854)
GLP-1 (1163)
Government (3479)
Grass and pollen (6)
Guidances (416)
Healthcare (14210)
Hematology (187)
HIV (104)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (132)
Immunology and inflammation (387)
Immuno-oncology (133)
Indications (242)
Infectious disease (2799)
Inflammatory bowel disease (237)
Inflation Reduction Act (16)
Influenza (136)
Intellectual property (332)
Interviews (554)
IPO (14202)
IRA (50)
Job creations (2520)
Job search strategy (1939)
JPM (69)
Kidney cancer (27)
Kidney disease (97)
Labor market (121)
Layoffs (575)
Leadership (59)
Legal (4394)
Licensing (30)
Liver cancer (104)
Longevity (40)
Lung cancer (956)
Lymphoma (512)
Machine learning (69)
Management (58)
Manufacturing (1223)
Marketing (13)
MASH (235)
Medical affairs (3)
Medical device (9618)
Medtech (9821)
Mergers & acquisitions (13936)
Metabolic disorders (1841)
mRNA (280)
Multiple sclerosis (220)
Multispecific (1)
NASH (20)
Netherlands (7)
Neurodegenerative disease (555)
Neuropsychiatric disorders (140)
Neuroscience (3672)
Neurotech (2)
NextGen: Class of 2026 (4927)
Non-profit (3251)
Now hiring (74)
Obesity (847)
Opinion (373)
Ovarian cancer (260)
Pain (285)
Pancreatic cancer (387)
Parkinson's disease (427)
Partnered (38)
Patents (686)
Patient advocacy (1)
Patient recruitment (903)
Patient selection (7)
Peanut (64)
People (41025)
Peptides (7)
Pharmaceutical (80)
Pharmacy benefit managers (34)
Phase 1 (20507)
Phase 2 (28841)
Phase 3 (22863)
Pipeline (11699)
Policy (334)
Postmarket research (1870)
Preclinical (8417)
Press Release (48)
Prostate cancer (353)
Psychedelics (89)
Radiopharmaceuticals (383)
Rare diseases (1400)
Real estate (3390)
Recruiting (73)
Regenerative medicine (3)
Regulatory (20370)
Reports (64)
Research institute (2014)
Resumes & cover letters (479)
Rett syndrome (48)
RNA editing (33)
RSV (86)
Schizophrenia (205)
Series A (353)
Series B (249)
Service/supplier (15)
Sickle cell disease (132)
Special edition (36)
Spinal muscular atrophy (187)
Sponsored (47)
Startups (2936)
State (2)
Stomach cancer (18)
Substance use disorders (20)
Supply chain (129)
Tariffs (81)
The Weekly (148)
Vaccines (1141)
Venture capital (157)
Weight loss (555)
Wet AMD (1)
Women's health (148)
Worklife (25)
Date
Today (115)
Last 7 days (463)
Last 30 days (2399)
Last 365 days (30045)
2026 (21790)
2025 (29681)
2024 (32404)
2023 (33987)
2022 (42252)
2021 (45633)
2020 (42080)
2019 (33912)
2018 (25719)
2017 (25793)
2016 (23504)
2015 (27884)
2014 (21089)
2013 (16344)
2012 (16866)
2011 (17334)
2010 (15564)
Location
Africa (698)
Alabama (107)
Alaska (6)
Arizona (297)
Arkansas (15)
Asia (33523)
Australia (6024)
California (14729)
Canada (3949)
China (1741)
Colorado (589)
Connecticut (637)
Delaware (476)
Europe (74181)
Florida (2119)
Georgia (452)
Hawaii (5)
Idaho (41)
Illinois (1269)
India (101)
Indiana (601)
Iowa (29)
Japan (684)
Kansas (138)
Kentucky (50)
Louisiana (59)
Maine (95)
Maryland (1666)
Massachusetts (10879)
Michigan (347)
Minnesota (712)
Mississippi (6)
Missouri (138)
Montana (29)
Nebraska (19)
Nevada (156)
New Hampshire (86)
New Jersey (3889)
New Mexico (35)
New York (3841)
North Carolina (1896)
North Dakota (10)
Northern California (7499)
Ohio (446)
Oklahoma (23)
Oregon (40)
Pennsylvania (2741)
Puerto Rico (27)
Rhode Island (48)
South America (894)
South Carolina (89)
Southern California (5849)
Tennessee (216)
Texas (2409)
United States (51503)
Utah (367)
Vermont (1)
Virginia (364)
Washington D.C. (74)
Washington State (1187)
West Virginia (3)
Wisconsin (174)
Wyoming (2)
540,205 Results for "t3 therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oliva Therapeutics Announces the Launch of Amerithroid™ (Thyroid Tablets, USP), a Naturally Derived T3/T4 Thyroid Hormone Replacement Therapy
July 2, 2026
·
2 min read
Press Releases
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
June 1, 2026
·
4 min read
Deals
Veranex Acquires Leading Preclinical Services Provider T3 Labs
Veranex today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia.
December 13, 2023
·
3 min read
Drug Development
T3D Therapeutics Announces Positive Top-Line Results from the Phase 2 PIONEER Trial of T3D-959 in Mild-To-Moderate Alzheimer’s Disease
T3D Therapeutics presented top-line results from its Phase 2 PIONEER study at the 16th international conference on Clinical Trials in Alzheimer’s Disease.
November 3, 2023
·
4 min read
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF.
November 22, 2023
·
3 min read
Drug Development
T3D Therapeutics Selected to Present Topline Results from the Phase 2 PIONEER Study of T3D-959 as Late Breaking News at the 16th Clinical Trials on Alzheimer’s Disease Conference (CTAD)
T3D Therapeutics, Inc. announced it has been selected to present, as late breaking news, topline results from its Phase 2 PIONEER clinical trial of T3D-959 in mild-to-moderate severity AD patients at the 16th international conference on Clinical Trials in Alzheimer’s Disease.
October 3, 2023
·
2 min read
Press Releases
Leading Alzheimer’s Expert Joins T3D Therapeutics’ Scientific Advisory Board
July 25, 2024
·
4 min read
Press Releases
A Novel Way to Reduce Alzheimer’s Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC
July 24, 2024
·
5 min read
Policy
M.T.3’s LAVURCHIN® Receives Japanese Pharmaceutical Regulatory Approval as a Radiosensitizer for Dogs
Malignant Tumor Treatment Technologies, Inc. (Headquarters: Tokyo; President and CEO: Toshiyasu Miyazaki; “M.T.3”) announced today that the Japanese pharmaceutical regulatory agency, the Ministry of Agriculture, Forestry, and Fisheries, has granted approval for LAVURCHIN® as a radiation sensitizing agent for dogs with stage III or stage IV nasal cavity tumors.
September 19, 2023
·
2 min read
Press Releases
ImmVira’s Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference
February 27, 2026
·
4 min read
1 of 54,021
Next